Jobubu Jarum Minahasa Tbk vs Merck Tbk. — how do they compare? Jobubu Jarum Minahasa Tbk trades at Rp81 (market cap 324B, 5.1M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 5.2× Jobubu Jarum Minahasa Tbk's market cap, and Jobubu Jarum Minahasa Tbk is more actively traded (5.1M versus 22.8K). Which is the better fit depends on your goals.
| BEER | MERK | |
|---|---|---|
Market Cap | 324B | 1.68T |
Volume | 5.1M | 22.8K |
Lot | 50.98K | 228 |
Turnover | 402.52M | 82.9M |
Average Price | 78.96 | 3,636.14 |
Value | 402.52M | 82.9M |
Indicative Equilibrium Price | 81 | 3,520 |
Indicative Equilibrium Volume | 250 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Jobubu Jarum Minahasa Tbk (the “Company”) was established based on Notarial Deed No. 19 of Theomaris Eddy Boham, S.H., M.H., dated July 25, 2018. The Company started its commercial operations since December 2018. The majority shareholder of the Company is PT Maju Minuman Minahasa and the Company's Ultimate Beneficiary Owner (UBO) is Nico Lieke.
Read more on BEER →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →